Cambridge GaN Devices (CGD), a spinout from Cambridge University in the UK, has secured $32 million in Series C financing to expand its operations in the UK, North America, Taiwan and Europe. The investment was led by an unnamed strategic investor and included participation from British Patient Capital as well as existing investors Parkwalk, BGF,… Read more…